EurekAlert! InContext Modules

Public Release: 10-Jul-2013

Genome Research
Researchers create method to rapidly identify specific strains of illness
Researchers from Boston University School of Medicine and George Washington University have developed a method to rapidly identify pathogenic species and strains causing illnesses, such as pneumonia, that could help lead to earlier detection of disease outbreaks and pinpoint effective treatments more quickly.

Public Release: 9-Jul-2013

PLOS ONE
Bird vaccine for West Nile Virus
University of British Columbia researchers have developed a vaccine to halt the spread of West Nile Virus among common and endangered bird species.

Public Release: 8-Jul-2013
Global Health Corps announces fifth class of fellows
Global Health Corps launched its fifth class of fellows today, during the opening of its annual Training Institute at Yale University. The 106 fellows hail from 16 countries and will serve with 44 health organizations in Burundi, Malawi, Rwanda, Uganda, Zambia and select cities in the United States. The newest fellowship class was selected from a pool of almost 4,000 applicants and highlights GHC's continued growth.

Public Release: 8-Jul-2013

Annals of Internal Medicine
Annals of Internal Medicine tip Sheet for 9 July 2013
Below is information about articles being published in the July 9 issue of Annals of Internal Medicine. The information is not intended to substitute for the full article as a source of information. Annals of Internal Medicine attribution is required for all coverage.

Public Release: 3-Jul-2013

Journal of Royal Society Interface
Research team improves immunization strategies for dengue fever in Thailand
Results have implications for designing more effective vaccine studies, says UMass Amherst biostatistician Nicholas Reich, who led the team. Dengue fever is a mosquito-transmitted viral infection that sickens 5 percent of the world's population each year and recently has begun to emerge in parts of the southeast United States. They report the first explicit quantitative evidence that short-term cross-protection exists since human experimental infection studies performed in the 1940s and 1950s by Albert Sabin.

NIH/National Institute of General Medical Sciences, Gates Foundation Vaccine Modeling Initiative

Public Release: 3-Jul-2013

Science Translational Medicine
Genetic signals reflect the evolutionary impact of cholera
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the Vibrio cholerae bacteria.

National Institutes of Health, Howard Hughes Medical Institute, American Cancer Society, Packard Foundation

Public Release: 2-Jul-2013
Bringing low-cost, inkjet-printed nano test strips to pakistan for drinking water tests
The National Academy of Sciences announced a three-year, $271,930 grant to chemist Vincent Rotello at the University of Massachusetts Amherst to develop, test and deploy new, sensitive, reliable and affordable inkjet-printed, nanoparticle-based test strips for detecting disease-causing bacteria in drinking water, with researchers at the Lahore University of Management Sciences, Pakistan.

US National Academy of Sciences

Public Release: 1-Jul-2013
New guidelines pave the road for achieving an AIDS-free generation
The Elizabeth Glaser Pediatric AIDS Foundation welcomes the World Health Organization's new HIV/AIDS treatment and prevention guidelines. For the first time, the 2013 guidelines combine recommendations across the continuum of HIV care and prevention programs, including expanding treatment eligibility for HIV-positive pregnant women, mothers, and children. These recommendations signify a major step forward in the global effort to achieve an AIDS-free generation, but will require a significant shift in current implementation efforts.

Public Release: 1-Jul-2013

Journal of Clinical Investigation
Cross-species malaria immunity induced by chemically attenuated parasites
In this issue of the Journal of Clinical Investigation, Michael Good and colleagues demonstrate that mice inoculated with a single species of attenuated parasite display immunity to multiple malaria species for over 100 days.

National Health and Medical Research Council Australia Fellowship, Griffith University

Public Release: 30-Jun-2013

7th IAS Conference on HIV Pathogenesis, Treatment and Prevention
DNDi and Cipla advance development of pediatric 4-in-1 ARVs to fulfill new WHO guidelines
The World Health Organization's new HIV treatment guidelines, released today at the 2013 International AIDS Society Conference, include new antiretroviral therapy recommendations for HIV-infected children, and will mean that more children will be on better treatments. The Drugs for Neglected Diseases initiative applauds the new guidelines and, with Cipla Ltd. and other partners, is expediting the development of urgently needed 4-in-1 ARVs adapted for babies and toddlers with HIV, to be delivered by 2015.

Public Release: 27-Jun-2013

Annals of Biomedical Engineering
Pneumonia revealed in a cough
A new method, which analyzes the sounds in a child's cough, could soon be used in poor, remote regions to diagnose childhood pneumonia reliably. According to Udantha Abeyratne from the University of Queensland in Australia and colleagues, this simple technique of recording coughs with a microphone on the patient's bedside table, has the potential to revolutionize the management of childhood pneumonia. Their work is published online in Springer's journal Annals of Biomedical Engineering.

Bill & Melinda Gates Foundation

Public Release: 26-Jun-2013
Cell biologist to begin work on discovering structure of malaria parasite genome
Plasmodium, which causes malaria, requires specific human and mosquito tissues to complete its life cycle. The progression and control of this life cycle could be better understood by studying changes of the 3-D structure of the parasite's genome. The University of California, Riverside and the University of Washington have received a four-year grant exceeding $2 million from the National Institutes of Health to discover this 3-D structure of Plasmodium's genome during the parasite's erythrocytic cycle.

National Institutes of Health

Public Release: 25-Jun-2013

Oncogene
USC research IDs potential treatment for deadly, HIV-related blood cancer
Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.

National Institutes of Health, STOP Cancer Foundation

Public Release: 25-Jun-2013
UW awarded $10 million to design paper-based diagnostic medical device
The University of Washington has received nearly $10 million from the US Department of Defense to continue a project aimed at building a small, paper-based device that could test for infectious diseases on-demand in areas where diagnostic capabilities are limited.

Public Release: 25-Jun-2013
Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinson's disease
Lauren Sciences LLC, a privately-held biotechnology company continuing development of its novel V-Smart™ platform technology, announced today the award of a second grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF). The company recently completed the first stage of developing V-Smart™-based therapeutics for the treatment of Parkinson's disease (PD), which was funded by MJFF, whereby it demonstrated targeted delivery of GDNF (glial-derived neurotrophic factor) to brain regions in which neurons degenerate during the course of PD.

The Michael J. Fox Foundation

Public Release: 24-Jun-2013
Sabin Vaccine Institute launches International Association of Immunization Managers
The Sabin Vaccine Institute today announced the launch of the newly-formed International Association of Immunization Managers. With the support of a five-year grant from the Bill and Melinda Gates Foundation, IAIM's objective is to help drive the achievement of national, regional and international immunization goals, including those in the Global Vaccine Action Plan, by fostering forward-thinking and superior management of immunization programs.

Bill & Melinda Gates Foundation

Public Release: 24-Jun-2013
Malawi trial saves newborn lives
A five-year program that mobilized communities to improve the quality of care for mothers and newborns reduced newborn mortality by 30 percent and saved at least 1,000 newborn lives in rural Malawi.

Public Release: 24-Jun-2013

Journal of General Physiology
How cholera-causing bacteria respond to pressure
Cholera persists in part because V. cholera, the bacteria that causes the disease, is able to survive in diverse environments ranging from the intestinal lumen, to fresh water, to estuaries, to the sea. A study in The Journal of General Physiology provides new insights about the membrane components of V. cholera that enable it to withstand otherwise deadly increases in osmotic pressure resulting from changes in its surrounding environment.

Public Release: 21-Jun-2013
Stanford's Environmental Ventures Projects program funds 7 new sustainability studies
The 2013 Environmental Venture Projects enable interdisciplinary research studies that propose practical solutions to major sustainability challenges.

Public Release: 21-Jun-2013
DoD-funded research: Can climate change heat up conflict?
A University of Maryland-led team of policy experts and scientists is seeking to understand how the impacts of climate change could affect civil conflicts. The team will develop new models of the relationship between conflict, socioeconomic conditions and climate. These will help project future conflict and develop interventions. The US Department of Defense is funding the research through a new three-year, $1.9 million grant -- part of its highly selective Minerva program of social science research.

US Department of Defense

Public Release: 19-Jun-2013
DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation
Coinciding with its tenth anniversary year, the Drugs for Neglected Diseases initiative (DNDi) has been granted the BBVA Foundation Frontiers of Knowledge Award in the Development Cooperation category. Its Executive Director, Bernard Pécoul, announced at a press conference that new drugs DNDi is working on "could dramatically change the management of some of these neglected diseases."

Public Release: 19-Jun-2013
GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health
Leading Japanese pharmaceutical companies, along with the Japanese government and the Bill & Melinda Gates Foundation, pledged their commitment to bolster Japan's contribution to global health through the Global Health Innovative Technology Fund, at a press conference held as a side event to the fifth Tokyo International Conference on African Development on June 1.

Public Release: 19-Jun-2013
Paralysed with fear: The story of polio
Thanks to vaccination, polio has been pushed to the brink of extinction-- but can we finish the job? This is one of the big questions which a University of Bristol academic addresses in his new book, published next week.

Public Release: 19-Jun-2013

The Lancet
Children from the poorest families are twice as likely to contract malaria than the least poor
New research has found that wherever malaria occurs, the poorest children within the world's most impoverished communities are twice as likely to contract malaria than the least poor, suggesting that poverty alleviation will protect children from malaria.

Department for International Development

Public Release: 18-Jun-2013

Nutrition Journal
Iodine in bread not enough for pregnant women
Research from the University of Adelaide shows that iodized salt used in bread is not enough to provide healthy levels of iodine for pregnant women and their unborn children.


			HOME DISCLAIMER PRIVACY POLICY TERMS & CONDITIONS CONTACT US TOP Copyright ©2013 by AAAS, the science society.